BV Dr. Devleeschouwer Els, pediatrie
ActiveSummary
BV Dr. Devleeschouwer Els, pediatrie has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €581k and a net result of €29k. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 49% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
83
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability73▼-1
Solvency88▲+4
Growth52▲+20
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45k at 30 days acceptable
Liquidity ample (current ratio 10.21 against 6.76 in 2024; short-term debt: 3.5% and cash: 12.1% of total assets), and 37.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
62.8%
Return on assets
3.2%
Age of the figures
15 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · A punctual record breaks
This company filed 9 consecutive financial years on time. The year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 02-02-2026, 2 days late. Weigh it accordingly: a break into the 1-to-90-day band measures 1.41% abnormal legal state, below the 1.66% market average. It is a change in behaviour, not evidence of elevated risk.
NBB · 10 filingsDeviation from the deadline
2025
2 d late
2024
on the day
2023
on the day
2022
4 d early
2021
on the day
2020
2 d early
2019
on the day
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close24-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€581k▲ 5.1%
2024 · €552k
2019: €561k
2020: €505k
2021: €565k
2022: €563k
2023: €564k
2024: €552k
2019 → 2025
Total assets
€926k▼ 1.6%
2024 · €941k
2019: €632k
2020: €996k
2021: €1.03M
2022: €1.04M
2023: €969k
2024: €941k
2019 → 2025
Net result
€29k▼ 23.2%
2024 · €38k
2019: €85k
2020: €-57k
2021: €61k
2022: €110k
2023: €2k
2024: €38k
2019 → 2025
Working capital
€300k▲ 12.1%
2024 · €268k
2019: €600k
2020: €180k
2021: €256k
2022: €257k
2023: €270k
2024: €268k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€565k-€563k▼ 0.4%€564k▲ 0.2%€552k▼ 2.1%€581k▲ 5.1%
Operating result€66k-€140k▲ 112%€7k▼ 95.1%€56k▲ 708%€38k▼ 30.8%
Net result€61k-€110k▲ 79.3%€2k▼ 98.1%€38k▲ 1,770%€29k▼ 23.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 31% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €926k
Fixed assets
€593k ▼ 5.4%
Current assets
€333k ▲ 5.9%
Equity and liabilities €926k
Equity
€581k ▲ 5.1%
Debt
€345k ▼ 11.2%
Debt's share of the balance-sheet total falls from 41.3% to 37.2%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€76k▼
2024 · €95k
Cash flow
€67k▼
2024 · €78k
Current ratio
10.21▲
2024 · 6.76
Debt to equity
0.59▼
2024 · 0.70
ROE
5.0%▼
2024 · 6.9%
ROA
3.2%▼
2024 · 4.1%
Interest coverage
16.06▼
2024 · 17.74
Debt ≤ 1 year
€33k▼
2024 · €47k
Debt > 1 year
€312k▼
2024 · €342k
Income taxes
€12k▼
2024 · €15k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 47 lines
Balance sheet
Code20242025
Assets
Total assets20/58€941k€926k▼
Fixed assets21/28€626k€593k▼
Tangible fixed assets22/27€626k€593k▼
Land and buildings22€567k€542k▼
Plant, machinery and equipment23€53k€45k▼
Furniture and vehicles24€5k€5k▲
Other tangible fixed assets26€1k€497▼
Current assets29/58€315k€333k▲
Amounts receivable within one year40/41€5k€11k▲
Other amounts receivable41€5k€11k▲
Current investments50/53€200k€200k=
Cash at bank and in hand54/58€105k€112k▲
Deferred charges and accrued income490/1€5k€10k▲
Equity and liabilities
Total equity and liabilities10/49€941k€926k▼
Equity10/15€552k€581k▲
Contributions10/11€26k€26k=
Reserves13€526k€555k▲
Distributable reserves133€526k€555k▲
Amounts payable17/49€388k€345k▼
Amounts payable after more than one year17€342k€312k▼
Financial debts170/4€342k€312k▼
Amounts payable within one year42/48€47k€33k▼
Current portion of amounts payable after more than one year42€29k€30k▲
Trade debts44€2k€2k▼
Suppliers440/4€2k€2k▼
Taxes, remuneration and social security45€2k€103▼
Taxes450/3€343€103▼
Remuneration and social security454/9€1k-
Other amounts payable47/48€13k€1k▼
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€40k€38k▼
Other operating charges640/8€4k€4k▲
Gross operating margin9900€99k€80k▼
Operating profit (loss)9901€56k€38k▼
Financial income75/76B€3k€8k▲
Recurring financial income75€3k€8k▲
Financial charges65/66B€5k€5k▼
Recurring financial charges65€5k€5k▼
Profit (loss) for the period before taxes9903€53k€41k▼
Income taxes67/77€15k€12k▼
Profit (loss) for the period9904€38k€29k▼
Profit (loss) for the period to be appropriated9905€38k€29k▼
Appropriation of the result
Profit (loss) to be appropriated9906€38k€29k▼
Transfer from equity791/2€18-
Transfer to equity691/2€37k€28k▼
To other reserves6921€37k€28k▼
Profit to be distributed694/7€833€859▲
Return on contributions (dividend)694€833€859▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
02-02
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 2 days late
2025
31-01
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-01
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
30-06
Financial
Liquidity doublescurrent ratio 9.01
Current ratio from 4.27 to 9.01; short-term debt falls from €79k to €34k.
27-01
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-06
Financial
Highest result since 2019net €110k ▲79.3%
Operating result €140k, net result €110k, both a record.
31-01
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-06
Financial
Back to profitnet €61k
Net result €61k after one loss-making year.
29-01
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-06
Financial
Weakest financial yearnet €-57k ▼166%
Net result drops to €-57k, the lowest in the series; recovery starts the following year.
31-01
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
30-01
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2017
29-12
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2016
29-12
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Waasmunster
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Nijverheidslaan 669250 WaasmunsterGround area
1,486 m²
Building footprint
197 m²
Volume, LiDAR
1,024 m³
Parcel 42023B0769/00V000, Flanders · tallest building 7.1 m, ±2 floors. Linked by address, not a title deed.
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 42023B0769/00V000 | Flanders | 1,486 m² | 1 · 197 m² | 7.1 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. VERSTRAETE – DR. RYCKAERT
BE 0887.229.504
Knokke-Heist · Eq €580,736
DOKTER MAARTEN WISSELS
BE 0881.399.111
Zonhoven · Eq €580,639
DR. MICHEL FRANCX
BE 0862.433.730
Schilde · Eq €580,252
DR. GUY VERSCHUEREN DERMATOLOOG
BE 0464.309.405
Antwerpen · Eq €580,126
Cabinet médical Docteurs DEWANDRE et COLIGNON
BE 0452.177.871
Dalhem · Eq €580,102
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,319 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded12-10-2011
Fiscal year end30-06
Activities, NACEBEL 2025
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.